Cargando…

Screening and Management of Dyslipidemia in Children and Adolescents

This review provides an overview of pediatric dyslipidemia emphasizing screening and treatment recommendations. The presence of risk factors for cardiovascular disease in childhood poses significant risk for the development of atherosclerotic cardiovascular disease and cardiovascular events in adult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schefelker, Juliette M., Peterson, Amy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656613/ https://www.ncbi.nlm.nih.gov/pubmed/36362707 http://dx.doi.org/10.3390/jcm11216479

Ejemplares similares

Impact of the COVID-19 pandemic on cardiometabolic health parameters in children with preexisting dyslipidemia
por: Schefelker, Juliette, et al.
Publicado: (2022)

Management of dyslipidemia in children
por: Kalra, Sanjay, et al.
Publicado: (2009)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice
por: Lim, Jung Sub
Publicado: (2013)

Clinician Responses to Pediatric Lipid Screens Suggestive of Severe Dyslipidemia
por: Zawacki, Amy W., et al.
Publicado: (2020)

Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents
por: Mosca, Sara, et al.
Publicado: (2022)

Dyslipidemia in Children and Adolescents: When and How to Diagnose and Treat?
por: Yoon, Jung Min
Publicado: (2014)

Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review
por: Hovsepian, Silva, et al.
Publicado: (2015)

Early echocardiographic screening for subclinical myocardial dysfunction in children and adolescents with dyslipidemia: why and when?
por: Lee, Hyun Gyung, et al.
Publicado: (2022)

Phytosterol supplementation in the treatment of dyslipidemia in children and adolescents: a systematic review
por: Mantovani, Luisa Montone, et al.
Publicado: (2020)

Contemporary Management of Dyslipidemia
por: Ferraro, Richard A., et al.
Publicado: (2022)

Dyslipidemia in women: etiology and management
por: Phan, Binh An P, et al.
Publicado: (2014)

Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents
por: Elmaoğulları, Selin, et al.
Publicado: (2015)

Dyslipidemia is Associated with Unfit and Overweight-Obese Children and Adolescents
por: Reuter, Cézane Priscila, et al.
Publicado: (2016)

No association between subclinical hypothyroidism and dyslipidemia in children and adolescents
por: Habib, Ashkan, et al.
Publicado: (2020)

High Prevalence of Dyslipidemia in Children and Adolescents: Opportunity for Prevention
por: Mangili, Leonardo
Publicado: (2020)

Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature
por: Esfarjani, Shahla V., et al.
Publicado: (2022)

Global Trends in the Epidemiology and Management of Dyslipidemia
por: Liu, Tianxiao, et al.
Publicado: (2022)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

Intranasal oxytocin drives coordinated social approach
por: Monari, Patrick K., et al.
Publicado: (2021)

Using Body Composition Groups to Identify Children and Adolescents at Risk of Dyslipidemia
por: Ofenheimer, Alina, et al.
Publicado: (2021)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Postprandial dyslipidemia in insulin resistant states in adolescent populations
por: Higgins, Victoria, et al.
Publicado: (2020)

Overview of guidelines for the management of dyslipidemia: EU perspectives
por: Giner-Galvañ, Vicente, et al.
Publicado: (2016)

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022)

Management of hypertension and dyslipidemia in Mexico: evidence, gaps, and approach
por: Morales-Villegas, Enrique C., et al.
Publicado: (2023)

The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
por: Al-Shaer, Moutasim H, et al.
Publicado: (2004)

Managing dyslipidemia in HIV/AIDS patients: challenges and solutions
por: Husain, Nazik Elmalaika OS, et al.
Publicado: (2014)

Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017)

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
por: Al Mousa, Eyas, et al.
Publicado: (2023)

ERICA: prevalence of dyslipidemia in Brazilian adolescents
por: Faria, José Rocha, et al.
Publicado: (2016)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Pair-bonding leads to convergence in approach behavior to conspecific vocalizations in California mice (Peromyscus californicus)
por: Rieger, Nathaniel S., et al.
Publicado: (2021)

Screening and socioeconomic associations of dyslipidemia in young adults
por: Hudson, Stephen E., et al.
Publicado: (2020)

Prevalence of Dyslipidemia among School-Age Children and Adolescents in Addis Ababa, Ethiopia
por: Mohammed, Ousman, et al.
Publicado: (2022)

Association of early life factors with dyslipidemia in children and adolescents: The CASPIAN-V study
por: Vard, Bahareh, et al.
Publicado: (2020)

The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
por: Noras, Katarzyna, et al.
Publicado: (2021)

Screening and managing depression in adolescents
por: Young, Jami F, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vkh1ju358vduj4ci1118o0e9qb